Literature DB >> 2962527

Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. The Framingham Heart Study.

D Levy1, K M Anderson, D D Savage, W B Kannel, J C Christiansen, W P Castelli.   

Abstract

The prevalence of and risk factors associated with echocardiographically determined left ventricular hypertrophy were examined in 4976 participants in the Framingham Heart Study (age, 17 to 90 years). Left ventricular hypertrophy was detected in 356 men (16%) and 513 women (19%). Prevalence increases dramatically with age (P less than 0.001), with 33% of men and 49% of women age 70 or older affected. A significant association between blood pressure and left ventricular hypertrophy is present and occurs at levels of systolic pressure below 140 mm Hg (age adjusted, P less than 0.001). There is a ninefold (women) to tenfold (men) increase from leanest to most obese group (age adjusted, P less than 0.001). In multivariate analysis, age, blood pressure, obesity, valve disease, and myocardial infarction are independently associated in both sexes. We conclude that left ventricular hypertrophy is a common echocardiographic finding for which several risk factors can be identified. These findings support weight reduction and blood pressure control for prevention or regression of this condition.

Entities:  

Mesh:

Year:  1988        PMID: 2962527     DOI: 10.7326/0003-4819-108-1-7

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  141 in total

Review 1.  Effects of gender on the renin-angiotensin system, blood pressure, and renal function.

Authors:  Amrit K Kang; Judith A Miller
Journal:  Curr Hypertens Rep       Date:  2002-04       Impact factor: 5.369

2.  Left ventricular hypertrophy: unresolved issues.

Authors:  J A Schoenberger
Journal:  Curr Hypertens Rep       Date:  1999-08       Impact factor: 5.369

Review 3.  Left ventricular hypertrophy: The relationship between the electrocardiogram and cardiovascular magnetic resonance imaging.

Authors:  Ljuba Bacharova; Martin Ugander
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-11-04       Impact factor: 1.468

Review 4.  Regression of left ventricular hypertrophy is a key goal of hypertension management.

Authors:  Rubin Zhang; Judy Crump; Efrain Reisin
Journal:  Curr Hypertens Rep       Date:  2003-08       Impact factor: 5.369

5.  [Arterial hypertension in patients with coronary artery disease].

Authors:  T Graf; H Schunkert
Journal:  Herz       Date:  2012-03       Impact factor: 1.443

6.  Echocardiographic left ventricular mass index predicts incident stroke in African Americans: Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Ervin R Fox; Nabhan Alnabhan; Alan D Penman; Kenneth R Butler; Herman A Taylor; Thomas N Skelton; Thomas H Mosley
Journal:  Stroke       Date:  2007-08-30       Impact factor: 7.914

Review 7.  Antihypertensive drugs and the heart.

Authors:  Joseph A Diamond; Robert A Phillips
Journal:  Curr Cardiol Rep       Date:  2004-11       Impact factor: 2.931

8.  Secular trends in echocardiographic left ventricular mass in the community: the Framingham Heart Study.

Authors:  Bernhard M Kaess; Philimon Gona; Martin G Larson; Susan Cheng; Jayashree Aragam; Satish Kenchaiah; Emelia J Benjamin; Ramachandran S Vasan
Journal:  Heart       Date:  2013-09-16       Impact factor: 5.994

9.  Changes in left ventricular structure and function in patients with white coat hypertension: cross sectional survey.

Authors:  M W Muscholl; H W Hense; U Bröckel; A Döring; G A Riegger; H Schunkert
Journal:  BMJ       Date:  1998-08-29

Review 10.  [Standard-ECG].

Authors:  Bernd-Dieter Gonska
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2008-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.